189 related articles for article (PubMed ID: 27214710)
21. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
Ruggeri M; Gisslinger H; Tosetto A; Rintelen C; Mannhalter C; Pabinger I; Heis N; Castaman G; Missiaglia E; Lechner K; Rodeghiero F
Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
[TBL] [Abstract][Full Text] [Related]
22. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
[TBL] [Abstract][Full Text] [Related]
23. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
24. Factor V Leiden as a risk factor for preterm birth--a population-based nested case-control study.
Hiltunen LM; Laivuori H; Rautanen A; Kaaja R; Kere J; Krusius T; Rasi V; Paunio M
J Thromb Haemost; 2011 Jan; 9(1):71-8. PubMed ID: 20946152
[TBL] [Abstract][Full Text] [Related]
25. ABO blood group and von Willebrand factor levels partially explained the incomplete penetrance of congenital thrombophilia.
Cohen W; Castelli C; Alessi MC; Aillaud MF; Bouvet S; Saut N; Brunet D; Barthet MC; Tregouet DA; Lavigne G; Morange PE
Arterioscler Thromb Vasc Biol; 2012 Aug; 32(8):2021-8. PubMed ID: 22628432
[TBL] [Abstract][Full Text] [Related]
26. Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis.
Nizankowska-Mogilnicka E; Adamek L; Grzanka P; Domagala TB; Sanak M; Krzanowski M; Szczeklik A
Eur Respir J; 2003 Jan; 21(1):25-30. PubMed ID: 12570104
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of factor V Leiden and prothrombin 20210 A variant in Bulgarian patients with pulmonary thromboembolism and deep venous thrombosis.
Boyanovsky B; Russeva M; Ganev V; Penev M; Baleva M
Blood Coagul Fibrinolysis; 2001 Dec; 12(8):639-42. PubMed ID: 11734663
[TBL] [Abstract][Full Text] [Related]
28. Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients - results from the Vienna Cancer And Thrombosis Study (CATS).
Pabinger I; Ay C; Dunkler D; Thaler J; Reitter EM; Marosi C; Zielinski C; Mannhalter C
J Thromb Haemost; 2015 Jan; 13(1):17-22. PubMed ID: 25381723
[TBL] [Abstract][Full Text] [Related]
29. High risk of recurrent venous thrombosis in patients with lower-leg cast immobilization.
Nemeth B; Timp JF; van Hylckama Vlieg A; Rosendaal FR; Cannegieter SC
J Thromb Haemost; 2018 Nov; 16(11):2218-2222. PubMed ID: 30160361
[TBL] [Abstract][Full Text] [Related]
30. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
[TBL] [Abstract][Full Text] [Related]
31. Factor V Leiden, prothrombin 20210A and the risk of venous thrombosis among cancer patients.
Kennedy M; Andreescu AC; Greenblatt MS; Jiang H; Thomas CA; Chassereau L; Wong C; Durda P; Cushman M
Br J Haematol; 2005 Feb; 128(3):386-8. PubMed ID: 15667542
[TBL] [Abstract][Full Text] [Related]
32. Risk of venous thrombosis in patients with major illnesses: results from the MEGA study.
Ocak G; Vossen CY; Verduijn M; Dekker FW; Rosendaal FR; Cannegieter SC; Lijfering WM
J Thromb Haemost; 2013 Jan; 11(1):116-23. PubMed ID: 23106832
[TBL] [Abstract][Full Text] [Related]
33. Malignancies, prothrombotic mutations, and the risk of venous thrombosis.
Blom JW; Doggen CJ; Osanto S; Rosendaal FR
JAMA; 2005 Feb; 293(6):715-22. PubMed ID: 15701913
[TBL] [Abstract][Full Text] [Related]
34. Factor V Leiden mutation in venous thrombosis in southeast Turkey.
Kalkanli S; Ayyildiz O; Tiftik N; Batun S; Isikdogan A; Ince H; Tekes S; Muftuoglu E
Angiology; 2006; 57(2):193-6. PubMed ID: 16518527
[TBL] [Abstract][Full Text] [Related]
35. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
de Visser MC; Guasch JF; Kamphuisen PW; Vos HL; Rosendaal FR; Bertina RM
Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320
[TBL] [Abstract][Full Text] [Related]
36. Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosis.
Meltzer ME; Lisman T; Doggen CJ; de Groot PG; Rosendaal FR
PLoS Med; 2008 May; 5(5):e97. PubMed ID: 18462012
[TBL] [Abstract][Full Text] [Related]
37. Below-knee cast immobilization and the risk of venous thrombosis: results from a large population-based case-control study.
van Adrichem RA; Debeij J; Nelissen RG; Schipper IB; Rosendaal FR; Cannegieter SC
J Thromb Haemost; 2014 Sep; 12(9):1461-9. PubMed ID: 25040873
[TBL] [Abstract][Full Text] [Related]
38. Different risk of deep vein thrombosis and pulmonary embolism in carriers with factor V Leiden compared with non-carriers, but not in other thrombophilic defects. Results from a large retrospective family cohort study.
Mäkelburg AB; Veeger NJ; Middeldorp S; Hamulyák K; Prins MH; Büller HR; Lijfering WM
Haematologica; 2010 Jun; 95(6):1030-3. PubMed ID: 20007142
[TBL] [Abstract][Full Text] [Related]
39. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation.
Procare-GEHT Group
Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352
[TBL] [Abstract][Full Text] [Related]
40. Combined genetic mutations have remarkable effect on deep venous thrombosis and/or pulmonary embolism occurence.
Simsek E; Yesilyurt A; Pinarli F; Eyerci N; Ulus AT
Gene; 2014 Feb; 536(1):171-6. PubMed ID: 24334115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
